Mesa Laboratories Inc /Co/ (NASDAQ:MLAB)
| Market Cap | $719.03M+64.6% |
| Revenue (ttm) | $251.32M+2.5% |
| Net Income | $6.67M+524.0% |
| EPS | $1.14+456.3% |
| Shares Out | 5.62M |
| PE Ratio | 108.42 |
| Forward PE | 10.69 |
| Dividend | $0.64(0.50%) |
| Ex-Dividend Date | Nov 30, 2026 |
| Volume | 76,014 |
| Open | $131.33 |
| Previous Close | $133.41 |
| Day's Range | $126.73 - $133.93 |
| 52-Week Range | $70.19 - $144.35 |
| Beta | 1.08 |
| Analysts | Hold |
| Price Target | $110.00(-14.02%) |
| Earnings Date | Feb 3, 2027 |
About MLAB
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
1 firm rating MLAB in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Nov 30, 2026Ex-dividend date
- Feb 3, 2027Earnings report
$MLAB stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in MLAB holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by MLAB's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
MLAB Estimated quarterly lobbying spending
Source: U.S. Senate LDA
MLAB Revenue by Segment or Geography
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New MLAB patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MLAB from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in MLAB
| IWMiShares Russell 2000 ETF | $18.57M |
| VTIVanguard Morningstar Total Stock Market ETF | $16.97M |
| VXFVanguard Extended Market ETF | $8.01M |
| FESMFidelity Enhanced Small Cap ETF | $7.61M |
| IWOiShares Russell 2000 Growth ETF | $6.80M |
| DFATDimensional - US Targeted Value ETF | $5.01M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from MLAB’s recent data — informational, not investment advice
What’s Behind the Score
News check: Q2 2027 earnings beat with margin expansion and inaugural full-year guidance signal positive momentum and management confidence.
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| KDVD | Keeley Dividend ETF | 2.18% |
| OASC | OneAscent Enhanced Small and Mid Cap ETF | 1.16% |
| JSML | Janus Henderson Small Cap Growth Alpha ETF | 1.14% |
| AIMS | Acuitas Small Cap Active ETF | 0.98% |
| SAWS | AAM Sawgrass U.S. Small Cap Quality Growth ETF | 0.97% |
| BUYO | KraneShares Man Buyout Beta Index ETF | 0.39% |
| RUSC | Russell Investments Exchange Traded Funds - Russell Investments US Small Cap Equity ETF | 0.35% |
| GNOM | Global X - Genomics & Biotechnology ETF | 0.30% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.19% |
| SMLV | State Street SPDR US Small Cap Low Volatility Index ETF | 0.18% |
| DES | WisdomTree U.S. SmallCap Dividend Fund | 0.15% |
| DMRS | DeltaShares S&P 600 Managed Risk ETF | 0.15% |
Weight is the stock’s share of each fund’s holdings.
